首页 > 最新文献

Breast disease最新文献

英文 中文
In-silico prediction of anti-breast cancer activity of ginger (Zingiber officinale) using machine learning techniques. 利用机器学习技术对生姜(Zingiber officinale)的抗乳腺癌活性进行室内预测。
Pub Date : 2024-01-01 DOI: 10.3233/BD-249002
Marisca Evalina Gondokesumo, Muhammad Rezki Rasyak

Introduction: Indonesian civilization extensively uses traditional medicine to cure illnesses and preserve health. The lack of knowledge on the security and efficacy of medicinal plants is still a significant concern. Although the precise chemicals responsible for this impact are unknown, ginger is a common medicinal plant in Southeast Asia that may have anticancer qualities.

Method: Using data from Dudedocking, a machine-learning model was created to predict possible breast anticancer chemicals from ginger. The model was used to forecast substances that block KIT and MAPK2 proteins, essential elements in breast cancer.

Result: Beta-carotene, 5-Hydroxy-74'-dimethoxyflavone, [12]-Shogaol, Isogingerenone B, curcumin, Trans-[10]-Shogaol, Gingerenone A, Dihydrocurcumin, and demethoxycurcumin were all superior to the reference ligand for MAPK2, according to molecular docking studies. Lycopene, [8]-Shogaol, [6]-Shogaol, and [1]-Paradol exhibited low toxicity and no Lipinski violations, but beta carotene had toxic predictions and Lipinski violations. It was anticipated that all three substances would have anticarcinogenic qualities.

Conclusion: Overall, this study shows the value of machine learning in drug development and offers insightful information on possible anticancer chemicals from ginger.

简介印度尼西亚文明广泛使用传统医药来治疗疾病和保护健康。但人们对药用植物的安全性和功效缺乏了解,这仍是一个重大问题。虽然造成这种影响的确切化学物质尚不清楚,但生姜是东南亚常见的药用植物,可能具有抗癌功效:方法:利用来自 Dudedocking 的数据,创建了一个机器学习模型来预测生姜中可能存在的乳腺癌抗癌化学物质。该模型用于预测可阻断 KIT 和 MAPK2 蛋白的物质,而 KIT 和 MAPK2 蛋白是乳腺癌的基本要素:结果:根据分子对接研究,β-胡萝卜素、5-羟基-74'-二甲氧基黄酮、[12]-肖高醇、异姜黄酮 B、姜黄素、反式-[10]-肖高醇、姜黄酮 A、二氢姜黄素和去甲氧基姜黄素都优于 MAPK2 的参考配体。番茄红素、[8]-Shogaol、[6]-Shogaol 和 [1]-Paradol 显示出低毒性,没有违反 Lipinski 规定的情况,但 beta 胡萝卜素有毒性预测和违反 Lipinski 规定的情况。预计这三种物质都具有抗致癌性:总之,这项研究显示了机器学习在药物开发中的价值,并为生姜中可能存在的抗癌化学物质提供了具有洞察力的信息。
{"title":"In-silico prediction of anti-breast cancer activity of ginger (Zingiber officinale) using machine learning techniques.","authors":"Marisca Evalina Gondokesumo, Muhammad Rezki Rasyak","doi":"10.3233/BD-249002","DOIUrl":"10.3233/BD-249002","url":null,"abstract":"<p><strong>Introduction: </strong>Indonesian civilization extensively uses traditional medicine to cure illnesses and preserve health. The lack of knowledge on the security and efficacy of medicinal plants is still a significant concern. Although the precise chemicals responsible for this impact are unknown, ginger is a common medicinal plant in Southeast Asia that may have anticancer qualities.</p><p><strong>Method: </strong>Using data from Dudedocking, a machine-learning model was created to predict possible breast anticancer chemicals from ginger. The model was used to forecast substances that block KIT and MAPK2 proteins, essential elements in breast cancer.</p><p><strong>Result: </strong>Beta-carotene, 5-Hydroxy-74'-dimethoxyflavone, [12]-Shogaol, Isogingerenone B, curcumin, Trans-[10]-Shogaol, Gingerenone A, Dihydrocurcumin, and demethoxycurcumin were all superior to the reference ligand for MAPK2, according to molecular docking studies. Lycopene, [8]-Shogaol, [6]-Shogaol, and [1]-Paradol exhibited low toxicity and no Lipinski violations, but beta carotene had toxic predictions and Lipinski violations. It was anticipated that all three substances would have anticarcinogenic qualities.</p><p><strong>Conclusion: </strong>Overall, this study shows the value of machine learning in drug development and offers insightful information on possible anticancer chemicals from ginger.</p>","PeriodicalId":9224,"journal":{"name":"Breast disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11191463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140956228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nipple-sparing mastectomy and immediate breast reconstruction by prepectoral implant for the management of giant phyllodes tumors: A case series. 巨型植物瘤的保乳乳房切除术和胸前假体即刻乳房重建术:病例系列。
Pub Date : 2024-01-01 DOI: 10.3233/BD-240011
Khaled M Abdelwahab, Sara Elsaeed, Omar Hamdy, Mahmoud M Saleh, Amr Hosam

Phyllodes tumor is an uncommon breast neoplasm that is present in variable sizes. Giant phyllodes are those larger than 10 cm in diameter. Clinically, giant phyllodes tumors present as a visible, rapidly growing mass distorting the breast contour. Such tumors with large size and rapid growth rate suggest a phyllode diagnosis of fibroadenoma. Planning a standard treatment strategy for these tumors is quite challenging. While adequate surgical excision with tumor-free resection margins is the standard of care for most giant phyllodes cases, borderline and malignant giant phyllodes tumors might require wider resections given their high recurrence rates. Some authors described total mastectomy as the treatment option for giant borderline and malignant phyllodes to obtain wide, clear margins. Between March 2022 and September 2023, our surgical oncology department presented and operated on three cases of giant phyllodes. They underwent a nipple-sparing mastectomy and immediate breast reconstruction using pre-pectoral silicone implants. We think that with such a procedure, we can benefit from the wide, safe margins of mastectomy that have been proven to decrease local recurrence rates while considering the aesthetic outcome.

叶状瘤是一种不常见的乳腺肿瘤,大小不一。巨型植物瘤是指直径大于 10 厘米的肿瘤。临床上,巨型植物瘤表现为明显的、快速生长的肿块,使乳房轮廓变形。此类肿瘤体积大、生长速度快,应诊断为纤维腺瘤。为这类肿瘤制定标准的治疗策略相当具有挑战性。对大多数巨型乳腺纤维瘤病例来说,无肿瘤切除边缘的充分手术切除是标准治疗方法,但鉴于其复发率高,边缘性和恶性巨型乳腺纤维瘤可能需要更广泛的切除。一些作者指出,全乳房切除术是治疗边缘性和恶性巨大蝶形花瘤的选择,以获得宽而清晰的边缘。2022 年 3 月至 2023 年 9 月期间,我院肿瘤外科接诊并手术治疗了三例巨大蝶形瘤患者。她们接受了乳头保留乳房切除术,并立即使用胸大肌前硅胶假体进行乳房重建。我们认为,通过这种手术,我们可以从乳房切除术的广泛、安全切缘中获益,这种切缘已被证明可以降低局部复发率,同时兼顾美学效果。
{"title":"Nipple-sparing mastectomy and immediate breast reconstruction by prepectoral implant for the management of giant phyllodes tumors: A case series.","authors":"Khaled M Abdelwahab, Sara Elsaeed, Omar Hamdy, Mahmoud M Saleh, Amr Hosam","doi":"10.3233/BD-240011","DOIUrl":"10.3233/BD-240011","url":null,"abstract":"<p><p>Phyllodes tumor is an uncommon breast neoplasm that is present in variable sizes. Giant phyllodes are those larger than 10 cm in diameter. Clinically, giant phyllodes tumors present as a visible, rapidly growing mass distorting the breast contour. Such tumors with large size and rapid growth rate suggest a phyllode diagnosis of fibroadenoma. Planning a standard treatment strategy for these tumors is quite challenging. While adequate surgical excision with tumor-free resection margins is the standard of care for most giant phyllodes cases, borderline and malignant giant phyllodes tumors might require wider resections given their high recurrence rates. Some authors described total mastectomy as the treatment option for giant borderline and malignant phyllodes to obtain wide, clear margins. Between March 2022 and September 2023, our surgical oncology department presented and operated on three cases of giant phyllodes. They underwent a nipple-sparing mastectomy and immediate breast reconstruction using pre-pectoral silicone implants. We think that with such a procedure, we can benefit from the wide, safe margins of mastectomy that have been proven to decrease local recurrence rates while considering the aesthetic outcome.</p>","PeriodicalId":9224,"journal":{"name":"Breast disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11307034/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141537628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of variables on breast self-examination: Potential barrier or enhancement of breast cancer prevention. 各种变量对乳房自我检查的影响:预防乳腺癌的潜在障碍或促进因素。
Pub Date : 2024-01-01 DOI: 10.3233/BD-249001
Hijrah Hijrah, Andi Nilawati Usman, Yusring Sanusi Baso, Syafruddin Syarif, Mardiana Ahmad, Zafitri Nulandari

Introduction: Breast self-examination (BSE) is an important tool for early detection of breast cancer and can contribute to increased awareness and familiarity with breast tissue. This study aimed to review factors that influenced BSE in preventing breast cancer.

Methods: In the initial stage of searching for journal articles, 186 journals were obtained, then screening was carried out within a time span of 2019-2024 and using Indonesian and English 54 journals. Of the 12 journals reviewed, the results showed that 4 journals reviewed had conducted pre and post-BSE practices, and 8 journal reviews conducted BSE practices conducted by students and health workers.

Results: Several factors play an important role in implementing BSE, namely age, knowledge, history of exposure to information, family history, ethnicity, and attitude. Overall, the study shows that the need to create awareness and educate women, especially rural women, on the importance of BSE as a preventive measure for breast cancer is paramount.

Conclusions: Factors influencing the implementation of BSE can be a barrier or an enhancement in breast cancer prevention.

简介乳房自我检查(BSE)是早期发现乳腺癌的重要工具,有助于提高人们对乳房组织的认识和熟悉程度。本研究旨在探讨影响 BSE 预防乳腺癌的因素:在搜索期刊论文的初始阶段,获得了 186 种期刊,然后在 2019-2024 年的时间跨度内,使用印尼语和英语对 54 种期刊进行了筛选。结果显示,在12篇期刊中,有4篇期刊进行了BSE前后的实践,8篇期刊进行了学生和卫生工作者的BSE实践:有几个因素对实施 BSE 起着重要作用,即年龄、知识、信息接触史、家族史、种族和态度。总之,研究表明,最重要的是要让妇女,尤其是农村妇女认识到 BSE 作为乳腺癌预防措施的重要性:结论:影响 BSE 实施的因素可能会阻碍乳腺癌的预防,也可能会促进乳腺癌的预防。
{"title":"Influence of variables on breast self-examination: Potential barrier or enhancement of breast cancer prevention.","authors":"Hijrah Hijrah, Andi Nilawati Usman, Yusring Sanusi Baso, Syafruddin Syarif, Mardiana Ahmad, Zafitri Nulandari","doi":"10.3233/BD-249001","DOIUrl":"10.3233/BD-249001","url":null,"abstract":"<p><strong>Introduction: </strong>Breast self-examination (BSE) is an important tool for early detection of breast cancer and can contribute to increased awareness and familiarity with breast tissue. This study aimed to review factors that influenced BSE in preventing breast cancer.</p><p><strong>Methods: </strong>In the initial stage of searching for journal articles, 186 journals were obtained, then screening was carried out within a time span of 2019-2024 and using Indonesian and English 54 journals. Of the 12 journals reviewed, the results showed that 4 journals reviewed had conducted pre and post-BSE practices, and 8 journal reviews conducted BSE practices conducted by students and health workers.</p><p><strong>Results: </strong>Several factors play an important role in implementing BSE, namely age, knowledge, history of exposure to information, family history, ethnicity, and attitude. Overall, the study shows that the need to create awareness and educate women, especially rural women, on the importance of BSE as a preventive measure for breast cancer is paramount.</p><p><strong>Conclusions: </strong>Factors influencing the implementation of BSE can be a barrier or an enhancement in breast cancer prevention.</p>","PeriodicalId":9224,"journal":{"name":"Breast disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11191488/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141183634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum to: Anti-IL-8 monoclonal antibodies inhibits the autophagic activity and cancer stem cells maintenance within breast cancer tumor microenvironment. 勘误:抗IL-8单克隆抗体抑制乳腺癌肿瘤微环境中的自噬活性和癌症干细胞的维持。
Pub Date : 2024-01-01 DOI: 10.3233/BD-241111
Seham Abou Shousha, Eman M Osman, Suzan Baheeg, Yasmine Shahine
{"title":"Erratum to: Anti-IL-8 monoclonal antibodies inhibits the autophagic activity and cancer stem cells maintenance within breast cancer tumor microenvironment.","authors":"Seham Abou Shousha, Eman M Osman, Suzan Baheeg, Yasmine Shahine","doi":"10.3233/BD-241111","DOIUrl":"10.3233/BD-241111","url":null,"abstract":"","PeriodicalId":9224,"journal":{"name":"Breast disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11301638/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141183624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contraceptive use with breast cancer incidence in Indonesia. 印度尼西亚的避孕药具使用与乳腺癌发病率。
Pub Date : 2024-01-01 DOI: 10.3233/BD-249007
Sulfiana Sulfiana, Prihantono Prihantono, Andi Nilawati Usman, Mardiana Ahmad, M Aryadi Arsyad, Andi Agus Mumang

Introduction: Breast cancer is the most common cancer in women worldwide and is a significant threat to public health. This study aims to conduct a systematic review of the relationship between hormonal contraceptive use and breast cancer incidence.

Methods: The search was conducted using Google Scholar, Proquest, Pubmed and one Indonesian database, Garuda, using English and Indonesian keywords. The inclusion criteria in this study were the publication year of the last five years, namely 2019-2023, English and Indonesian language, case-control observational research, using the Indonesian population, and full-text access.

Results: A total of 165 studies were obtained from the Google Scholar database, including 104 studies. The overall multivariate analysis revealed that there was a statistically significant association of hormonal contraception with the incidence of breast cancer with OR values in the range of 2-6.

Conclusions: The findings of this systematic study suggest that the use of hormones can contribute to hormonal imbalances that further increase breast cell proliferation and disrupt gene expression, resulting in uncontrolled cell development/cancer. In addition, the findings recommend increasing the number of studies on this topic to obtain more adequate and possibly more diverse information.

导言:乳腺癌是全球妇女最常见的癌症,对公众健康构成重大威胁。本研究旨在对激素避孕药的使用与乳腺癌发病率之间的关系进行系统回顾:方法:使用 Google Scholar、Proquest、Pubmed 和一个印尼数据库 Garuda,使用英语和印尼语关键词进行检索。本研究的纳入标准为:最近五年(即 2019-2023 年)的发表年份、英语和印尼语、病例对照观察研究、使用印尼人口、全文获取:从谷歌学术数据库中共获得165项研究,其中包括104项研究。总体多变量分析显示,激素避孕与乳腺癌的发病率有显著的统计学关联,OR 值在 2-6 之间:这项系统性研究的结果表明,激素的使用会导致荷尔蒙失衡,从而进一步增加乳腺细胞的增殖并扰乱基因表达,导致细胞不受控制地发展/癌变。此外,研究结果还建议增加有关这一主题的研究数量,以获得更充分、可能更多样的信息。
{"title":"Contraceptive use with breast cancer incidence in Indonesia.","authors":"Sulfiana Sulfiana, Prihantono Prihantono, Andi Nilawati Usman, Mardiana Ahmad, M Aryadi Arsyad, Andi Agus Mumang","doi":"10.3233/BD-249007","DOIUrl":"10.3233/BD-249007","url":null,"abstract":"<p><strong>Introduction: </strong>Breast cancer is the most common cancer in women worldwide and is a significant threat to public health. This study aims to conduct a systematic review of the relationship between hormonal contraceptive use and breast cancer incidence.</p><p><strong>Methods: </strong>The search was conducted using Google Scholar, Proquest, Pubmed and one Indonesian database, Garuda, using English and Indonesian keywords. The inclusion criteria in this study were the publication year of the last five years, namely 2019-2023, English and Indonesian language, case-control observational research, using the Indonesian population, and full-text access.</p><p><strong>Results: </strong>A total of 165 studies were obtained from the Google Scholar database, including 104 studies. The overall multivariate analysis revealed that there was a statistically significant association of hormonal contraception with the incidence of breast cancer with OR values in the range of 2-6.</p><p><strong>Conclusions: </strong>The findings of this systematic study suggest that the use of hormones can contribute to hormonal imbalances that further increase breast cell proliferation and disrupt gene expression, resulting in uncontrolled cell development/cancer. In addition, the findings recommend increasing the number of studies on this topic to obtain more adequate and possibly more diverse information.</p>","PeriodicalId":9224,"journal":{"name":"Breast disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11191510/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141092530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early detection of self-breast examination using smartphone breast application. 使用智能手机乳房应用程序进行自我乳房检查的早期检测。
Pub Date : 2024-01-01 DOI: 10.3233/BD-249004
Nur Indah, Andi Nilawati Usman, Yusring Sanusi Baso, Syafruddin Syarif, Mardiana Ahmad, Andi Agus Mumang

Introduction: Breast self-examination (BSE) is a screening method that can help empower, raise awareness, and detect breast abnormalities in women. The use of smartphone applications for breast cancer early detection is able to overcome some of these barriers. This study aimed to conduct a systematic review to assess the effectiveness of the effect of using smartphone application-based technology on breast cancer.

Methods: Google Scholar, PubMed, Proquest, and ScienceDirect were searched for "breast self-examination" and "smartphone application" literature. This literature's study designs were quasi-experimental, prospective cohort, qualitative, and systematic review. The study contained five unique research projects with 828 varied participants.

Results: The use of smartphones was seen to have advantages in terms of increased knowledge, perceived vulnerability, barriers to breast self-examination (BSE), self-efficacy, health motivation, and BSE practices.

Conclusions: The utilization of smartphone apps related to BSE is shown through the availability, accessibility, and focus of information and is in line with the Health Belief Model (HBM).

简介乳房自我检查(BSE)是一种筛查方法,有助于增强妇女的能力、提高妇女的意识和检测乳房异常。使用智能手机应用程序进行乳腺癌早期检测能够克服其中的一些障碍。本研究旨在开展一项系统性综述,评估使用基于智能手机应用的技术对乳腺癌的影响效果:方法:在 Google Scholar、PubMed、Proquest 和 ScienceDirect 中搜索 "乳房自我检查 "和 "智能手机应用 "的文献。这些文献的研究设计包括准实验、前瞻性队列、定性和系统回顾。研究包含五个独特的研究项目,共有 828 名不同的参与者:结果:使用智能手机在增加知识、感知脆弱性、乳房自我检查(BSE)障碍、自我效能感、健康动机和 BSE 实践方面具有优势:结论:与 BSE 相关的智能手机应用程序的使用体现在信息的可用性、可及性和关注点上,并且符合健康信念模型 (HBM)。
{"title":"Early detection of self-breast examination using smartphone breast application.","authors":"Nur Indah, Andi Nilawati Usman, Yusring Sanusi Baso, Syafruddin Syarif, Mardiana Ahmad, Andi Agus Mumang","doi":"10.3233/BD-249004","DOIUrl":"10.3233/BD-249004","url":null,"abstract":"<p><strong>Introduction: </strong>Breast self-examination (BSE) is a screening method that can help empower, raise awareness, and detect breast abnormalities in women. The use of smartphone applications for breast cancer early detection is able to overcome some of these barriers. This study aimed to conduct a systematic review to assess the effectiveness of the effect of using smartphone application-based technology on breast cancer.</p><p><strong>Methods: </strong>Google Scholar, PubMed, Proquest, and ScienceDirect were searched for \"breast self-examination\" and \"smartphone application\" literature. This literature's study designs were quasi-experimental, prospective cohort, qualitative, and systematic review. The study contained five unique research projects with 828 varied participants.</p><p><strong>Results: </strong>The use of smartphones was seen to have advantages in terms of increased knowledge, perceived vulnerability, barriers to breast self-examination (BSE), self-efficacy, health motivation, and BSE practices.</p><p><strong>Conclusions: </strong>The utilization of smartphone apps related to BSE is shown through the availability, accessibility, and focus of information and is in line with the Health Belief Model (HBM).</p>","PeriodicalId":9224,"journal":{"name":"Breast disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11191427/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141183589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lectins as a promising therapeutic agent for breast cancer: A review. 作为乳腺癌治疗剂前景看好的凝集素:综述。
Pub Date : 2024-01-01 DOI: 10.3233/BD-230047
Keerti Singh, Lokita Agrawal, Rhea Gupta, Divyam Singh, Meghavi Kathpalia, Navkiran Kaur

Efficient treatment of cancer has been a subject of research by scientists for many years. Current treatments for cancer, such as radiotherapy, chemotherapy and surgery have been used in traditional combination therapy, but they have major setbacks like non-specificity, non-responsiveness in certain cancer types towards treatment, tumor recurrence, etc. Epidemiological data has shown that breast cancer accounts for 14% of cancer cases occurring in Indian women. In recent years, scientists have started to focus on the use of natural compounds like lectins obtained from various sources to counter the side effects of traditional therapy. Lectins like Sambucus nigra Agglutinin, Maackia amurensis lectin, Okra lectins, Haliclona caerulea lectin, Sclerotium rolfsii lectin, etc., have been discovered to have both diagnostic and therapeutic potential for breast cancer patients. Lectins have been found to have inhibitory effects on various cancer cell activities such as neo-angiogenesis, causing cell cycle arrest at the G1 phase, and inducing apoptosis. The major idea behind the use of lectins in cancer diagnostics and therapeutics is their capability to bind to glycosylated proteins that are expressed on the cell surface. This review focuses on an exploration of the roles of post-translational modification in cancer cells, especially glycosylation, and the potential of lectins in cancer diagnosis and therapeutics.

多年来,癌症的高效治疗一直是科学家们研究的课题。目前的癌症治疗方法,如放疗、化疗和手术等,都是传统的综合疗法,但这些疗法都有很大的缺陷,如没有特异性、某些癌症类型对治疗没有反应、肿瘤复发等。流行病学数据显示,乳腺癌占印度女性癌症病例的 14%。近年来,科学家们开始关注使用从各种来源获得的天然化合物(如凝集素)来对抗传统疗法的副作用。人们发现,像 Sambucus nigra Agglutinin、Maackia amurensis 凝集素、秋葵凝集素、Haliclona caerulea 凝集素、Sclerotium rolfsii 凝集素等凝集素对乳腺癌患者具有诊断和治疗潜力。研究发现,凝集素对癌细胞的各种活动具有抑制作用,如抑制新血管生成、使细胞周期停滞在 G1 期、诱导细胞凋亡等。将凝集素用于癌症诊断和治疗的主要理念是,凝集素能够与细胞表面表达的糖基化蛋白质结合。本综述将重点探讨糖基化等翻译后修饰在癌细胞中的作用,以及凝集素在癌症诊断和治疗中的潜力。
{"title":"Lectins as a promising therapeutic agent for breast cancer: A review.","authors":"Keerti Singh, Lokita Agrawal, Rhea Gupta, Divyam Singh, Meghavi Kathpalia, Navkiran Kaur","doi":"10.3233/BD-230047","DOIUrl":"10.3233/BD-230047","url":null,"abstract":"<p><p>Efficient treatment of cancer has been a subject of research by scientists for many years. Current treatments for cancer, such as radiotherapy, chemotherapy and surgery have been used in traditional combination therapy, but they have major setbacks like non-specificity, non-responsiveness in certain cancer types towards treatment, tumor recurrence, etc. Epidemiological data has shown that breast cancer accounts for 14% of cancer cases occurring in Indian women. In recent years, scientists have started to focus on the use of natural compounds like lectins obtained from various sources to counter the side effects of traditional therapy. Lectins like Sambucus nigra Agglutinin, Maackia amurensis lectin, Okra lectins, Haliclona caerulea lectin, Sclerotium rolfsii lectin, etc., have been discovered to have both diagnostic and therapeutic potential for breast cancer patients. Lectins have been found to have inhibitory effects on various cancer cell activities such as neo-angiogenesis, causing cell cycle arrest at the G1 phase, and inducing apoptosis. The major idea behind the use of lectins in cancer diagnostics and therapeutics is their capability to bind to glycosylated proteins that are expressed on the cell surface. This review focuses on an exploration of the roles of post-translational modification in cancer cells, especially glycosylation, and the potential of lectins in cancer diagnosis and therapeutics.</p>","PeriodicalId":9224,"journal":{"name":"Breast disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11307042/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141436392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of neuro-Behcet's disease in a patient with operable HER2-positive breast cancer during neoadjuvant chemotherapy: A case report. 一名可手术的 HER2 阳性乳腺癌患者在新辅助化疗期间出现神经性贝赫切特病:病例报告。
Pub Date : 2024-01-01 DOI: 10.3233/BD-230026
Taketo Nakai, Hirohito Seki, Akitsugu Makino, Yoshie Kadota, Takuji Kaburagi, Takehiro Okumura, Tsuyoshi Karahashi

Background: Neuro-Behcet's disease (NBD) is a variant of Behcet's disease (BD). To our knowledge, there have been no previous reports on concurrent NBD in breast cancer patients undergoing chemotherapy.

Case presentation: Our patient had a history of BD and was asymptomatic. She was diagnosed with human epidermal growth factor receptor 2-positive breast cancer by core needle biopsy and was administered neoadjuvant chemotherapy. After four courses, in addition to the aggravation of the existing adverse events, headache, fever, dysarthria, and muscle weakness in the upper left and lower extremities appeared. On admission, she was diagnosed with acute NBD, and steroid therapy was initiated. After her symptoms improved gradually, she was discharged. Then, she underwent mastectomy and axillary lymph node dissection for breast cancer. Trastuzumab and pertuzumab plus tamoxifen were administered postoperatively. Two years postoperatively, no recurrence of breast cancer and NBD was noted.

Conclusion: When chemotherapy is administered to breast cancer patients with a history of BD, it is necessary to select chemotherapy with as few adverse events as possible and to continue with treatment while paying attention to the risk of NBD.

背景:神经-贝赫切特病(NBD)是贝赫切特病(BD)的一种变异型。据我们所知,此前还没有关于正在接受化疗的乳腺癌患者并发 NBD 的报道:病例介绍:我们的患者有 BD 病史,无任何症状。通过核心针活检,她被确诊为人表皮生长因子受体 2 阳性乳腺癌,并接受了新辅助化疗。四个疗程后,除了原有的不良反应加重外,还出现了头痛、发热、构音障碍、左上肢和下肢肌无力等症状。入院时,她被诊断为急性 NBD,并开始接受类固醇治疗。症状逐渐好转后,她出院了。随后,她接受了乳腺癌切除术和腋窝淋巴结清扫术。术后使用了曲妥珠单抗和百妥珠单抗加他莫昔芬。术后两年,乳腺癌和 NBD 均未复发:结论:对有 BD 病史的乳腺癌患者进行化疗时,有必要选择不良反应尽可能少的化疗方法,并在继续治疗的同时注意 NBD 的风险。
{"title":"Development of neuro-Behcet's disease in a patient with operable HER2-positive breast cancer during neoadjuvant chemotherapy: A case report.","authors":"Taketo Nakai, Hirohito Seki, Akitsugu Makino, Yoshie Kadota, Takuji Kaburagi, Takehiro Okumura, Tsuyoshi Karahashi","doi":"10.3233/BD-230026","DOIUrl":"10.3233/BD-230026","url":null,"abstract":"<p><strong>Background: </strong>Neuro-Behcet's disease (NBD) is a variant of Behcet's disease (BD). To our knowledge, there have been no previous reports on concurrent NBD in breast cancer patients undergoing chemotherapy.</p><p><strong>Case presentation: </strong>Our patient had a history of BD and was asymptomatic. She was diagnosed with human epidermal growth factor receptor 2-positive breast cancer by core needle biopsy and was administered neoadjuvant chemotherapy. After four courses, in addition to the aggravation of the existing adverse events, headache, fever, dysarthria, and muscle weakness in the upper left and lower extremities appeared. On admission, she was diagnosed with acute NBD, and steroid therapy was initiated. After her symptoms improved gradually, she was discharged. Then, she underwent mastectomy and axillary lymph node dissection for breast cancer. Trastuzumab and pertuzumab plus tamoxifen were administered postoperatively. Two years postoperatively, no recurrence of breast cancer and NBD was noted.</p><p><strong>Conclusion: </strong>When chemotherapy is administered to breast cancer patients with a history of BD, it is necessary to select chemotherapy with as few adverse events as possible and to continue with treatment while paying attention to the risk of NBD.</p>","PeriodicalId":9224,"journal":{"name":"Breast disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11307018/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141537627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genomic signatures in breast cancer in a real-world setting: Experience in a Brazilian Northeastern Center. 现实世界中乳腺癌的基因组特征:巴西东北部中心的经验。
Pub Date : 2024-01-01 DOI: 10.3233/BD-230044
Sabas Carlos Vieira, Cristiane Amaral Dos Reis, Mariana Elvas Feitosa Holanda, Danilo Rafael da Silva Fontinele, Alessandro Igor Cavalcanti Leal, Fernanda Teresa de Lima

Objective: We aim to evaluate the indication and use of genomic signatures in breast cancer patients and outcomes who in patients undergoing adjuvant chemotherapy or not.

Methods: This is a retrospective study of breast cancer patients managed in a private oncology clinic in Teresina, from November 2014 to February 2021. All patients with an indication of genomic signature were included. Clinical and pathological variables, use of genomic signatures, treatment and follow-up were obtained. The nomogram to predict Oncotype DX results (University of Tennessee Medical Center) was also calculated. Clinical risk calculation was based on MINDACT, using the modified version of Adjuvant Online. The genetic signatures performed were: the Oncotype, MammaPrint and EndoPredict.

Results: Fifty (50) female patients were included in the study. The mean age of the participants was 57.1 years. Among the patients receiving a genomic signature (26-52.0%), there was a change in treatment in 8 (30.7%) cases. Chemotherapy was indicated in four patients, It was contraindicated in another four patients. Treatment changed in 30.7% of the tested patients. Chemotherapy was indicated for those who would not receive it before. It was contraindicated in patients who would previously undergo chemotherapy.

目的我们旨在评估基因组特征在乳腺癌患者中的适应症和使用情况,以及患者是否接受辅助化疗的结果:这是一项回顾性研究,研究对象是 2014 年 11 月至 2021 年 2 月期间在特雷西纳一家私人肿瘤诊所接受治疗的乳腺癌患者。所有有基因组特征指征的患者均被纳入研究范围。研究人员了解了临床和病理变量、基因组特征的使用、治疗和随访情况。还计算了预测 Oncotype DX 结果的提名图(田纳西大学医学中心)。临床风险计算以 MINDACT 为基础,使用改良版的 Adjuvant Online。进行的基因特征描述包括:Oncotype、MammaPrint 和 EndoPredict:研究共纳入了 50 名女性患者。参与者的平均年龄为 57.1 岁。在接受基因组特征分析的患者中(26-52.0%),有 8 例(30.7%)改变了治疗方案。4名患者接受了化疗,另有4名患者禁用化疗。30.7%的受检患者改变了治疗方法。化疗适用于以前不接受化疗的患者。之前接受过化疗的患者禁忌化疗。
{"title":"Genomic signatures in breast cancer in a real-world setting: Experience in a Brazilian Northeastern Center.","authors":"Sabas Carlos Vieira, Cristiane Amaral Dos Reis, Mariana Elvas Feitosa Holanda, Danilo Rafael da Silva Fontinele, Alessandro Igor Cavalcanti Leal, Fernanda Teresa de Lima","doi":"10.3233/BD-230044","DOIUrl":"10.3233/BD-230044","url":null,"abstract":"<p><strong>Objective: </strong>We aim to evaluate the indication and use of genomic signatures in breast cancer patients and outcomes who in patients undergoing adjuvant chemotherapy or not.</p><p><strong>Methods: </strong>This is a retrospective study of breast cancer patients managed in a private oncology clinic in Teresina, from November 2014 to February 2021. All patients with an indication of genomic signature were included. Clinical and pathological variables, use of genomic signatures, treatment and follow-up were obtained. The nomogram to predict Oncotype DX results (University of Tennessee Medical Center) was also calculated. Clinical risk calculation was based on MINDACT, using the modified version of Adjuvant Online. The genetic signatures performed were: the Oncotype, MammaPrint and EndoPredict.</p><p><strong>Results: </strong>Fifty (50) female patients were included in the study. The mean age of the participants was 57.1 years. Among the patients receiving a genomic signature (26-52.0%), there was a change in treatment in 8 (30.7%) cases. Chemotherapy was indicated in four patients, It was contraindicated in another four patients. Treatment changed in 30.7% of the tested patients. Chemotherapy was indicated for those who would not receive it before. It was contraindicated in patients who would previously undergo chemotherapy.</p>","PeriodicalId":9224,"journal":{"name":"Breast disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11307088/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141598439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breast gel based on Boswellia serrata, Betaine and myo-Inositol improves cyclic mastodynia in fertile women: A retrospective clinical study. 基于乳香、甜菜碱和肌醇的乳房凝胶可改善育龄妇女的周期性乳房疼痛:回顾性临床研究
Pub Date : 2024-01-01 DOI: 10.3233/BD-240012
Moira Burratti, Giuseppina Morano, Chiara Pasquale, Grazia Di Fonso, Loredana Costabile

Background: The management of mastodynia plays a central role in improving women quality of life. Despite its high occurrence, specific therapeutic guidelines for mastalgia are still lacking. Available therapies include unspecific anti-inflammatories, even though they may often expose to undesirable effects and low compliance.

Objective: The aim of this study was to highlight the efficacy of the topical application of combined natural molecules including Boswellia serrata, Betaine and myo-Inositol in improving cyclic mastalgia.

Methods: In this retrospective pilot clinical study, patients with cyclic mastalgia applied a specific breast gel for three months. The severity of the pain was measured through the Visual Analogue Score (VAS) in the treated group compared to untreated one. Treated patients also filled in a questionnaire evaluating acceptance and safety of the breast gel.

Results: This pilot clinical study demonstrated for the first time the efficacy of the topical application of a breast gel based on Betaine, Boswellia serrata, and myo-Inositol in improving cyclic mastodynia. The completed questionnaires also revealed high levels of acceptance, as both safety and compliance.

Conclusions: Besides confirming the positive effects of these natural molecules in the management of conditions affecting breast physiology - so far evaluated as oral supplementation - the obtained results pave the way for further studies supporting the use of such molecules as a tailored medical device in the management of breast pain, thus also opening toward a combined oral and topical approach.

背景:乳房疼痛的治疗在提高妇女生活质量方面发挥着重要作用。尽管乳房疼痛的发生率很高,但目前仍缺乏针对乳房疼痛的具体治疗指南。现有的疗法包括非特异性消炎药,尽管这些药物可能经常会产生不良影响,而且依从性较低:本研究旨在强调乳香、甜菜碱和肌醇等多种天然分子的局部应用对改善周期性乳痛症的疗效:在这项回顾性试点临床研究中,周期性乳房疼痛患者使用了一种特定的乳房凝胶,为期三个月。通过视觉模拟评分(VAS)测量治疗组与未治疗组的疼痛严重程度。接受治疗的患者还填写了一份问卷,对乳房凝胶的接受度和安全性进行评估:这项试验性临床研究首次证明了局部使用以甜菜碱、乳香和肌醇为基础的乳房凝胶对改善周期性乳房疼痛的疗效。完成的调查问卷还显示,该产品在安全性和依从性方面都获得了高度认可:结论:除了证实这些天然分子在治疗影响乳房生理机能的病症方面具有积极作用(迄今为止,这些天然分子都是以口服补充剂的形式进行评估的),所获得的结果还为进一步的研究铺平了道路,这些研究支持将这些分子用作治疗乳房疼痛的定制医疗设备,从而也为口服和外用相结合的方法开辟了道路。
{"title":"Breast gel based on Boswellia serrata, Betaine and myo-Inositol improves cyclic mastodynia in fertile women: A retrospective clinical study.","authors":"Moira Burratti, Giuseppina Morano, Chiara Pasquale, Grazia Di Fonso, Loredana Costabile","doi":"10.3233/BD-240012","DOIUrl":"10.3233/BD-240012","url":null,"abstract":"<p><strong>Background: </strong>The management of mastodynia plays a central role in improving women quality of life. Despite its high occurrence, specific therapeutic guidelines for mastalgia are still lacking. Available therapies include unspecific anti-inflammatories, even though they may often expose to undesirable effects and low compliance.</p><p><strong>Objective: </strong>The aim of this study was to highlight the efficacy of the topical application of combined natural molecules including Boswellia serrata, Betaine and myo-Inositol in improving cyclic mastalgia.</p><p><strong>Methods: </strong>In this retrospective pilot clinical study, patients with cyclic mastalgia applied a specific breast gel for three months. The severity of the pain was measured through the Visual Analogue Score (VAS) in the treated group compared to untreated one. Treated patients also filled in a questionnaire evaluating acceptance and safety of the breast gel.</p><p><strong>Results: </strong>This pilot clinical study demonstrated for the first time the efficacy of the topical application of a breast gel based on Betaine, Boswellia serrata, and myo-Inositol in improving cyclic mastodynia. The completed questionnaires also revealed high levels of acceptance, as both safety and compliance.</p><p><strong>Conclusions: </strong>Besides confirming the positive effects of these natural molecules in the management of conditions affecting breast physiology - so far evaluated as oral supplementation - the obtained results pave the way for further studies supporting the use of such molecules as a tailored medical device in the management of breast pain, thus also opening toward a combined oral and topical approach.</p>","PeriodicalId":9224,"journal":{"name":"Breast disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11380272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142104475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Breast disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1